ATE554393T1 - Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen - Google Patents
Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungenInfo
- Publication number
- ATE554393T1 ATE554393T1 AT04765283T AT04765283T ATE554393T1 AT E554393 T1 ATE554393 T1 AT E554393T1 AT 04765283 T AT04765283 T AT 04765283T AT 04765283 T AT04765283 T AT 04765283T AT E554393 T1 ATE554393 T1 AT E554393T1
- Authority
- AT
- Austria
- Prior art keywords
- diseases
- adipor2
- therapeutics
- diagnostics
- diseases associated
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 5
- 101000589401 Homo sapiens Adiponectin receptor protein 2 Proteins 0.000 title abstract 3
- 102100032358 Adiponectin receptor protein 2 Human genes 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 208000025966 Neurological disease Diseases 0.000 abstract 2
- 208000012931 Urologic disease Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000014001 urinary system disease Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000054182 human ADIPOR2 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03021898 | 2003-09-27 | ||
| PCT/EP2004/010383 WO2005031345A2 (en) | 2003-09-27 | 2004-09-16 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554393T1 true ATE554393T1 (de) | 2012-05-15 |
Family
ID=34384566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04765283T ATE554393T1 (de) | 2003-09-27 | 2004-09-16 | Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US20070053913A1 (de) |
| EP (1) | EP1671122B1 (de) |
| JP (1) | JP2007506950A (de) |
| AT (1) | ATE554393T1 (de) |
| ES (1) | ES2386440T3 (de) |
| WO (1) | WO2005031345A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5386056B2 (ja) | 2003-11-04 | 2014-01-15 | 第一三共株式会社 | 抗腫瘍剤 |
| WO2007125324A1 (en) * | 2006-04-26 | 2007-11-08 | Astrazeneca Ab | Method of screening for an antagonist of adiponectin receptor 2 and uses thereof |
| CA2707182C (en) | 2007-11-30 | 2017-12-12 | Siemens Healthcare Diagnostics Inc. | Adiponectin receptor fragments and methods of use |
| EP2422199B1 (de) | 2009-04-23 | 2018-07-25 | Siemens Healthcare Diagnostics Inc. | Monomere und dimere formen von adiponectin-rezeptorfragmenten sowie verwendungsverfahren dafür |
| US9291629B2 (en) | 2011-04-11 | 2016-03-22 | Siemens Healthcare Diagnostics Inc. | Adiponectin receptor C-terminal fragments (CTF)-immunoglobulin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020173474A1 (en) * | 1993-02-12 | 2002-11-21 | President And Fellows Of Harvard College | Methods & materials involving dimerization-mediated regulation of biological events |
| US7087426B2 (en) * | 1996-09-11 | 2006-08-08 | Agrigenesis Biosciences Ltd. | Materials and methods for the modification of plant lignin content |
| CA2440144A1 (en) * | 2001-03-14 | 2002-09-19 | Oklahoma Medical Research Foundation | Methods for reducing fat by administration of adiponectin |
| US20030083261A1 (en) * | 2001-04-30 | 2003-05-01 | Hongtao Yu | Class of 12mer peptides that inhibit the function of the mitotic check point protein Mad2 |
| ATE483976T1 (de) * | 2001-06-05 | 2010-10-15 | Exelixis Inc | Gfats als modifikatoren des p53-wegs und verwendungsverfahren |
| DE60335216D1 (de) * | 2002-12-29 | 2011-01-13 | Nissan Chemical Ind Ltd | Adiponektin-rezeptor und dafür kodierendes gen |
| DE602004022632D1 (de) * | 2003-01-09 | 2009-10-01 | Beth Israel Hospital | Verwendung von adiponectin zur diagnose von krebs |
| US7435808B2 (en) * | 2003-06-25 | 2008-10-14 | Bristol-Myers Squibb Company | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2 |
| US20090222931A1 (en) * | 2004-05-13 | 2009-09-03 | Tsinghua University | Novel identified oncogene with kinase-domain (nok) |
| TWI404931B (zh) * | 2009-02-20 | 2013-08-11 | 財團法人國家同步輻射研究中心 | 癌化生物樣本之檢測方法及其使用之檢驗試劑 |
| EP2501722A4 (de) * | 2009-11-19 | 2013-05-01 | Univ Singapore | Verfahren zur herstellung t-zellen-rezeptor-ähnlicher monoklonaler antikörper und anwendungen davon |
-
2004
- 2004-09-16 WO PCT/EP2004/010383 patent/WO2005031345A2/en not_active Ceased
- 2004-09-16 ES ES04765283T patent/ES2386440T3/es not_active Expired - Lifetime
- 2004-09-16 AT AT04765283T patent/ATE554393T1/de active
- 2004-09-16 JP JP2006527319A patent/JP2007506950A/ja active Pending
- 2004-09-16 EP EP04765283A patent/EP1671122B1/de not_active Expired - Lifetime
- 2004-09-16 US US10/572,882 patent/US20070053913A1/en not_active Abandoned
-
2010
- 2010-05-26 US US12/787,632 patent/US20110136107A1/en not_active Abandoned
-
2013
- 2013-07-03 US US13/934,880 patent/US20140093507A1/en not_active Abandoned
-
2017
- 2017-01-17 US US15/408,417 patent/US20170368171A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007506950A (ja) | 2007-03-22 |
| ES2386440T3 (es) | 2012-08-21 |
| US20110136107A1 (en) | 2011-06-09 |
| US20140093507A1 (en) | 2014-04-03 |
| WO2005031345A3 (en) | 2005-07-07 |
| US20070053913A1 (en) | 2007-03-08 |
| EP1671122A2 (de) | 2006-06-21 |
| EP1671122B1 (de) | 2012-04-18 |
| US20170368171A1 (en) | 2017-12-28 |
| WO2005031345A2 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
| TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
| WO2005022146A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13) | |
| ATE471520T1 (de) | Diagnostika und therapeutika für mit dem g- protein-gekoppelten rezeptor adipor1 (adipor1) assoziierte krankheiten | |
| WO2005106491A3 (en) | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) | |
| WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| WO2005031345A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) | |
| WO2005085466A3 (en) | Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2) | |
| WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
| WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
| WO2004038421A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
| WO2005075675A3 (en) | Diagnostics and therapeutics for diseases associated with putative cysteine protease 1 (prs1) | |
| WO2005093091A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26) | |
| WO2004097034A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4) | |
| WO2005074969A3 (en) | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1) | |
| WO2005026719A3 (en) | Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3) | |
| WO2004106934A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) | |
| WO2005090994A3 (en) | Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1) | |
| WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
| WO2005040791A3 (en) | Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) | |
| WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
| DE602004014261D1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten | |
| WO2005101009A3 (en) | Diagnostics and therapeutics for diseases associated with tachykinin receptor 2 (tacr2) | |
| WO2005052586A3 (en) | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3) | |
| WO2005026724A3 (en) | Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a5 (slc22a5) |